Ohm Pharmaceuticals Lab. Pvt. Ltd

Name

Ohm Pharmaceuticals Lab. Pvt. Ltd

Legal name

Ohm Pharmaceuticals Lab. Pvt. Ltd

Website

https://opl.com.np

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industry

Oral Solid Dose (OSD) Generics (HLAIABAD)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• WHO-GMP certified drugs
• Hormonal pharmaceuticals
• Urology medications

Headquarters

HQ city

Kathmandu

HQ country

Nepal

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from manufacturing and selling pharmaceutical products including General medicines, Hormones, Steroids, and Urology medications across Nepal.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Ohm Pharmaceuticals Lab. Pvt. Ltd (OPL) manufactures and sells branded pharmaceutical formulations across four therapeutic categories: General medicines, Hormones, Steroids, and Urology. Products are produced at a WHO-GMP certified manufacturing facility in Bhaktapur, Nepal, and distributed domestically through a dealer network covering all seven provinces of Nepal. The company was the first in Nepal to receive WHO-GMP certification for hormonal drugs.

Product overview

Ohm Pharmaceuticals Lab. Pvt. Ltd (OPL) is a Nepalese pharmaceutical company manufacturing medicines across four primary therapeutic categories: General, Hormones, Steroids, and Urology. The General portfolio spans anti-infectives (AZICARE, AGT, XIFIM, ZOLBEN, LEFLOX, OPIFLOX), gastro-intestinal products (RENOV, ENTIC FR, PANOM, OMIRA, SOKOOL, SOKOOL-O, EVALAX, EVATOL), analgesics/NSAIDs (ALOFEN, OMFLAM, OMICOX, OMNI, OMSPAZ, SIDAZE, LOTEMP), respiratory/allergy products (AIRY 10, AIRY-L, ALERT, KESTINE, WELFEX, ACC, COFSY-BM, COFSY-D, COFSY-D PLUS), metabolic/cardiovascular products (DITIC, OBESLIM, COQ, RYTHM, HEPACT, NEURISE), neurological products (PREGALIN, PREGALIN-M, LACOFIT, MECOBAL), and urology products (ALIZER, MILAGE, OVACT). The Hormones portfolio includes reproductive health and oncology products such as ENDOSIS (dienogest), APEIN (megestrol acetate), ELET (letrozole), ESTROMA, GYNOCARE, CORGES, FEMIVA, FEMININE, MEDOX, MISTOL (misoprostol), PREGNO, PREGNO KIT, and UNWANTED. The Steroids portfolio includes INCOR M (methylprednisolone), ZACOR (deflazacort), and TOFACT (tofacitinib). The Urology portfolio includes PROS-D, PROSFLO, PROSTAM, PROSTIF, and UROXATE. The company also manufactures a range of antispasmodics (BIOSPAN, IBOSYN, DOVE), supplements (B-COM), and anti-vertigo medication (VERTIN). OPL is the first pharmaceutical company in Nepal to receive WHO-GMP certification for hormonal drugs.

Differentiator

Problem solved

Functional benefit

Products and services

• RENOV (Vonoprazan) Vonoprazan-based potassium-competitive acid blocker (PCAB) used to treat acid-related diseases such as erosive esophagitis, GERD, stomach ulcers, and H. pylori eradication in combination therapy. Targeted at patients and prescribers needing first-in-class acid suppression.
• DITIC (Empagliflozin) SGLT2 inhibitor antidiabetic agent for adults with type 2 diabetes mellitus, also indicated for heart failure with reduced ejection fraction, chronic kidney disease, and cardiovascular risk reduction.
• APEIN (Megestrol Acetate) Synthetic progestin used as an appetite stimulant for anorexia, cachexia, or significant weight loss in cancer or AIDS patients, and for palliative treatment of advanced hormone-sensitive breast and endometrial cancers.
• ENTIC FR (Esomeprazole) Proton pump inhibitor for treating excess stomach acid conditions including duodenal and gastric ulcers, erosive esophagitis, GERD, and Zollinger-Ellison syndrome.
• ENDOSIS (Dienogest 2mg) Progestin used for the treatment of endometriosis, acting as an agonist at the progesterone receptor with potent progestagenic effect causing endometrial atrophy.
• INCOR M (Methylprednisolone) Corticosteroid available in 4mg, 8mg, and 16mg tablet formulations, used for endocrine disorders, allergic disorders, skin disorders, respiratory diseases, rheumatoid arthritis, and other inflammatory conditions.
• ZACOR (Deflazacort) Glucocorticoid available in 6mg and 30mg tablets, used for Duchenne muscular dystrophy, juvenile chronic arthritis, polymyalgia rheumatica, and bronchial asthma.
• ELET (Letrozole) Non-steroidal aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women, available as 2.5mg tablets.
• COQ (Coenzyme Q10) Antioxidant supplement available in 30mg and 60mg capsules, used for cardiovascular diseases, male infertility, pre-eclampsia prevention, muscle cramps, and dermatological applications.
• OBESLIM (Orlistat 120mg) Dietary fat absorption inhibitor and lipase inhibitor used for obesity management including weight loss, weight maintenance, and reducing risk of weight regain after prior weight loss.
• MISTOL (Misoprostol 200mcg) Prostaglandin E1 analog used for cervical ripening, inducing uterine contractions, labor induction, preventing postpartum hemorrhage, and in combination with mifepristone for medical termination of pregnancy.
• RYTHM (Melatonin) Sleep hormone available in 3mg and 10mg tablet formulations, used for short-term treatment of jet-lag, delayed sleep phase syndrome, shift-work sleep disorders, and tinnitus.
• PREGNO KIT Medical termination kit for pregnancy up to 63 days (LMP), complete abortion regimen, and induction in IUFD cases.
• UNWANTED (Emergency Contraception) Emergency contraception tablet used within 72 hours of unprotected intercourse or contraceptive failure.
• PROS-D Urology product used for BPH symptom relief, reducing risk of acute urinary retention, and delaying or avoiding BPH surgery.
• PROSFLO Urology product used for aiding passage of ureteral stones, symptomatic relief in prostatitis, and improving urinary flow in males and females.
• PROSTAM Urology alpha-blocker used for acute urinary retention and bladder outlet obstruction support, and aiding passage of small stones.
• PROSTIF Urology product used for symptomatic relief in enlarged prostate, reducing risk of acute urinary retention, and decreasing need for BPH surgery.
• UROXATE Urinary tract spasmolytic used for urinary frequency, incontinence, dysuria, nocturia, bladder spasms, and cystitis.
• LEFLOX (Levofloxacin) Fluoroquinolone antibiotic used for respiratory infections, urinary tract infections, and prostatitis.
• AZICARE (Azithromycin) Macrolide antibiotic used for middle ear infections, strep throat, pneumonia, traveller's diarrhea, intestinal infections, and sexually transmitted infections including chlamydia.
• LOTEMP (Paracetamol) Paracetamol-based analgesic and antipyretic used for fever, headache, toothache, cold and flu symptoms, post-vaccination fever, and mild to moderate pain.
• OMIRA (Omeprazole) Proton pump inhibitor used for GERD, reflux esophagitis, NSAID-induced gastritis, functional dyspepsia, and H. pylori combination therapy.
• PREGALIN-M (Pregabalin + Methylcobalamin) Pregabalin formulation used for neuropathic pain, fibromyalgia, sciatica, complex regional pain syndrome, and nerve pain with add-on seizure therapy.
• PANOM (Pantoprazole) Proton pump inhibitor used for GERD, heartburn, gastric and duodenal ulcers, stress ulcers, and Zollinger-Ellison syndrome.
• OVACT (Tolterodine/Solifenacin) Anti-muscarinic agent used for overactive bladder, neurogenic detrusor overactivity, urge urinary incontinence, frequent urination, and bladder control improvement.
• OMFLAM (NSAID formulation) NSAID used for headache, migraine, dental pain, musculoskeletal pain, menstrual cramps, postoperative pain, and fever.
• GYNOCARE (Progesterone) Progesterone formulation used for luteal phase support in IVF/infertility, threatened or recurrent miscarriage, dysmenorrhea and PMS, and endometriosis.
• CORGES (Progesterone 200) Progesterone supplement used for luteal phase support in IVF/IUI, secondary amenorrhea, hormone replacement therapy, threatened/recurrent miscarriage, and menstrual irregularities.
• ESTROMA (Adjuvant Hormonal Therapy) Adjuvant hormonal therapy agent used for recurrence risk reduction in hormone receptor-positive tumors.
• ALIZER (Disodium Hydrogen Citrate) Urinary alkalizer and alkalinizing agent used for acidosis following diarrhea, painful/burning micturition, renal tubular acidosis, uremic acidosis, and kidney stones.
• MILAGE Pharmaceutical product used for erectile dysfunction, benign prostatic hyperplasia, lower urinary tract symptoms, and pulmonary arterial hypertension.
• PROBEN (Domperidone) Gastrokinetic agent used for gastroparesis, nausea and vomiting, heartburn, and bloating.
• PREGNO (Mifepristone) Used for early pregnancy termination combined with misoprostol, and as a first-trimester progesterone blocker.

Named customers8 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Cipla Limited: Indian global pharmaceutical major with a large generic and hormone/steroid footprint and active Nepal/South Asia distribution. Comparable as a much larger incumbent competing with OPL through imports on overlapping generic molecules.
• Sun Pharmaceutical Industries Ltd. India's largest generic pharmaceutical company with wide dosage-form capabilities including hormonal and steroid products, exporting into Nepal. Comparable as a broad incumbent whose generics compete with OPL's domestic portfolio.
• Dr. Reddy's Laboratories Ltd. Large Indian generic manufacturer with strong emerging-markets distribution including Nepal. Comparable as a broad incumbent whose generics, including hormone and steroid products, compete head-to-head with OPL's offerings.

Direct peers

• Time Pharmaceuticals Pvt. Ltd. Nepalese pharmaceutical company manufacturing and marketing branded generic formulations with nationwide distribution in Nepal. Closely comparable on geography, dosage-form capabilities, and dealer-led sales.
• Citizen Pharmaceuticals Pvt. Ltd. Nepalese pharmaceutical manufacturer producing and distributing generics domestically. Comparable on country focus, multi-category product portfolio, and B2B pharmacy distribution model.
• Magnachem International Pharmaceuticals: Nepal-based pharmaceutical manufacturer with an extensive branded-generic portfolio. Directly comparable on country scope, therapeutic breadth, and manufacturing-plus-distribution model.
• National Healthcare Pvt. Ltd. Nepalese pharmaceutical manufacturer with a broad branded-generic portfolio sold through domestic distribution. Directly comparable to OPL on Nepal-focused manufacturing and dealer-led GTM.
• Lomus Pharmaceuticals Pvt. Ltd. Established Nepalese pharmaceutical company manufacturing generics across multiple categories for the domestic market. Comparable on country focus, product mix breadth, and channel-led distribution.
• Deurali-Janata Pharmaceuticals Pvt. Ltd. One of Nepal's largest domestic pharmaceutical manufacturers producing branded generics across multiple therapeutic categories with nationwide distribution. Highly comparable to OPL on geography, business model (own-brand generics), and manufacturing scope.
• Asian Pharmaceuticals Pvt. Ltd. Nepalese pharmaceutical manufacturer producing a diverse generic portfolio for the domestic market. Comparable on product breadth, country focus, and channel-based sales.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ohm-pharmaceuticals-lab-pvt-ltd

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ohm Pharmaceuticals Lab. Pvt. Ltd